Mucoprotective agent

1 marketed 1 in Phase 3

This page covers all Mucoprotective agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

Rebamipide 2% ophthalmic solution · Samsung Medical Center · Ophthalmology
Rebamipide promotes ocular surface healing and reduces inflammation by stimulating mucin secretion and protecting epithelial cells.

Phase 3 pipeline (1)

Non-PPI (Gefarnate) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Gastroenterology
Gefarnate is a mucoprotective agent that enhances gastric mucus production and strengthens the gastric mucosal barrier to protect against acid-induced damage.